Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fang Bian
Observed name:
F Bian
Institution:
People's Hospital of Cangzhou
Observed institution:
People's Hospital of Cangzhou
ORCID:
0009-0005-1219-4345
Observed ORCID:
0009-0005-1219-4345
OpenAlex ID:
A5101966622
Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial
2024
·
Weiqing Wang
, Stephen C. Bain
, et al.
·
Diabetologia
·
39
PDF
Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial
2025
·
Dalong Zhu
, Jianhua Ma
, et al.
·
Diabetologia
·
8
Efficacy and safety of visepegenatide as an add-on therapy to metformin in patients with type 2 diabetes: a randomised, double-blind, parallel, placebo-controlled, phase 3 study
2024
·
Xiaoling Cai
, Linong Ji
, et al.
·
The Lancet Regional Health - Western Pacific
·
1
[Efficacy and safety of combining olorigliflozin with metformin in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy].
2026
·
Y F He
, Z F Cheng
, et al.
·
PubMed
Correction: Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial
2026
·
Dalong Zhu
, Jianhua Ma
, et al.
·
Diabetologia
PDF
Current progress of the inflammasomes in aortic aneurysm and aortic dissection
2018
·
Jun Cui
, Fang Bian
·
DOAJ (DOAJ: Directory of Open Access Journals)
Show more works
View as search
Works count:
6
Citation count:
48
H-index:
2
I10-index:
1
Year
Topic
Type